You are here

Article info

Article menu
Basic and translational research
Extended report
Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr−/− mice

Authors

  • Ashley J Wilhelm Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA PubMed articlesGoogle scholar articles
  • Jillian P Rhoads Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA PubMed articlesGoogle scholar articles
  • Nekeithia S Wade Department of Microbiology, Carter Center for Immunology Research, University of Virginia, Charlottesville, Virginia, USA PubMed articlesGoogle scholar articles
  • Amy S Major Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Amy S Major, Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, 2220 Pierce Avenue, Room 352 PRB, Nashville, TN 37232, USA; amy.major{at}vanderbilt.edu
View Full Text

Citation

Wilhelm AJ, Rhoads JP, Wade NS, et al
Dysregulated CD4+ T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr−/− mice
Annals of the Rheumatic Diseases 2015;74:778-785.

Publication history

  • Received April 10, 2013
  • Revised November 30, 2013
  • Accepted December 15, 2013
  • First published January 6, 2014.
Online issue publication 
October 25, 2017

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/